| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gyre Therapeutics, Inc. (GYRE) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. GYRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 2.81M | $19.84M | - | |
| CEO | 2.57M | $18.14M | -10,315 | |
| 10% | 2.14M | $15.16M | - | |
| Dir | 100.0K | $707.0K | - | |
| CFO | 95.1K | $672.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $12.06 | $48,220.00 | - | -33.4% | -37.6% | |
| Mar 12, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.57 | $46,280.00 | - | -22.9% | -33.1% | |
| Mar 10, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $10.19 | $40,776.11 | - | -17.7% | -21.0% | |
| Mar 6, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $10.89 | $43,560.00 | - | -19.8% | -27.9% | |
| Mar 4, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.05 | $44,180.00 | - | -29.5% | -24.3% | |
| Feb 28, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.37 | $45,480.00 | - | -18.4% | -29.0% | |
| Feb 26, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.50 | $46,000.00 | - | -11.6% | -25.9% | |
| Feb 24, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.30 | $45,190.36 | - | -3.4% | -20.2% | |
| Feb 20, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $12.35 | $49,380.00 | - | -17.4% | -34.1% | |
| Feb 18, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $12.22 | $48,860.00 | - | -12.5% | -35.4% |